United States · Bill · HR
H.R. 4702 (118th)
Securing Gene Synthesis Act
Introduced
18 July 2023
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
5 December 2025
Summary
Securing Gene Synthesis Act This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 18 July 2023
Introduced in House (PDF)
Introduced in House · EN · 18 July 2023
Introduced in House
summary · EN · 18 July 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/4702
- Open data entity: https://api.congress.gov/v3/bill/118/hr/4702